AGGvsBIS
iShares Core U.S. Aggregate Bond ETF against ProShares UltraShort Nasdaq Biotechnology — the fee, the flows, the book, and a year head-to-head.
Head to head
| AGG | BIS | |
|---|---|---|
| Expense ratio | 0.030% | 0.95% |
| Assets | $127.8B | $2M |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | +$1K |
| Return, YTD | -3.8% | -42.2% |
| Return, 1 year | -5.1% | -51.3% |
| Avg daily volume | 12.6M | 12K |
| Holdings | 11675 | 7 |
| Listed | Sep 22, 2003 | Apr 9, 2010 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS